8-K current report · filed Oct 26, 2026

West Pharmaceutical Services (WST) 8-K Current Report: October 26, 2026

Item 2.03Item 1.01Item 1.02WST overview

Short answer

West Pharmaceutical Services (WST) filed an 8-K current report with the SEC on October 26, 2026 reporting Item 2.03 (Creation of a Direct Financial Obligation), Item 1.01 (Entry into a Material Definitive Agreement), Item 1.02 (Termination of a Material Definitive Agreement). $130.0 million outstanding under the 2019 Credit Agreement repaid in full on October 26, 2026.

West Pharmaceutical Services 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.02 · Termination of a Material Definitive Agreement

  • $130.0 million outstanding under the 2019 Credit Agreement repaid in full on October 26, 2026
  • Existing credit facility terminated after refinancing with proceeds from the New Credit Agreement
  • No early termination penalties incurred, limiting refinancing-related costs
  • Debt structure shifted to the New Credit Agreement, with terms and maturity detailed in Item 2.03

Item 2.03 · Creation of a Direct Financial Obligation

  • New unsecured credit agreement: $750 million revolving facility plus $200 million term loan
  • Five-year maturity, with term-loan amortization beginning March 31, 2028 and remaining balance due at maturity
  • Proceeds available for working capital, capital expenditures, acquisitions, share repurchases and refinancing existing debt
  • Interest margins tied to net leverage: 1.000%-1.500% for SOFR revolver borrowings and 1.125%-1.750% for SOFR term loans
  • Net leverage covenant capped at 3.50x, or 4.00x during qualifying material acquisition periods

Other items in this filing:

  • Item 1.01: Entry into a Material Definitive Agreement

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other West Pharmaceutical Services 8-K filings

Get the next WST 8-K as it lands

Follow WST for push alerts, or ask the research agent what this filing means.